Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22959465.
- Also identified by DOI 10.1016/j.biomaterials.2012.08.030 and PMC identifier 4176881.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We previously reported that nanoceria can slow retinal degeneration in the tubby mouse for two weeks by multiple systemic injections. However, the long-term protection of retinal structure and function by directly deliver of nanoceria to the eye had not been explored. In this study, 172 ng of nanoceria in 1 μl saline (1 mm) were intravitreally injected into tubby P7 pups and assays were performed at P28, P49, P80 and P120. The expression of antioxidant associated genes and photoreceptor-specific genes was significantly up regulated, the mislocalization of rod and cone opsins was decreased, and retinal structure and function were protected. These findings demonstrate that nanoceria can function as catalytic antioxidants in vivo and may be broad spectrum therapeutic agents for multiple types of ocular diseases.
Medical subject headings
- Cerium
- Photoreceptor Cells, Vertebrate
- Retina
- Retinal Degeneration